stopwords, and 2-character and smaller words are excluded
Papers by T Hunter
Total: 1331, Nodes: 439, Word count: 3586, All words count: 5382
View: Overview. Sorted by GCS.
Page 1 of 7: [ 1 2 3 4 5 6 7 ]
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 1 | KINASE | 78 | 17.8 | 202 | 11534
|
| 2 | PROTEIN | 84 | 19.1 | 222 | 10619
|
| 3 | TYROSINE | 64 | 14.6 | 447 | 9924
|
| 4 | PHOSPHORYLATION | 72 | 16.4 | 311 | 8688
|
| 5 | PROTEIN-KINASE | 21 | 4.8 | 157 | 8005
|
| 6 | PROTEIN-TYROSINE | 41 | 9.3 | 140 | 7351
|
| 7 | KINASES | 29 | 6.6 | 101 | 6710
|
| 8 | RECEPTOR | 42 | 9.6 | 151 | 6652
|
| 9 | ROUS-SARCOMA | 18 | 4.1 | 366 | 4998
|
| 10 | ACTIVITY | 24 | 5.5 | 112 | 4949
|
| 11 | VIRUS | 27 | 6.2 | 354 | 4793
|
| 12 | CATALYTIC | 3 | 0.7 | 32 | 4566
|
| 13 | DOMAINS | 6 | 1.4 | 34 | 4035
|
| 14 | FAMILY | 4 | 0.9 | 28 | 3980
|
| 15 | HUMAN | 19 | 4.3 | 96 | 3938
|
| 16 | PROTEINS | 28 | 6.4 | 200 | 3927
|
| 17 | PROTEIN-KINASES | 14 | 3.2 | 81 | 3728
|
| 18 | DEDUCED | 2 | 0.5 | 23 | 3618
|
| 19 | CONSERVED | 1 | 0.2 | 20 | 3599
|
| 20 | FEATURES | 1 | 0.2 | 20 | 3599
|
| 21 | PHYLOGENY | 1 | 0.2 | 20 | 3599
|
| 22 | GROWTH-FACTOR | 12 | 2.7 | 110 | 3537
|
| 23 | TRANSCRIPTION | 11 | 2.5 | 24 | 3530
|
| 24 | TRANSFORMING | 16 | 3.6 | 154 | 3426
|
| 25 | SIGNALING | 19 | 4.3 | 43 | 3375
|
| 26 | SUBSTRATE | 21 | 4.8 | 89 | 3369
|
| 27 | PHOSPHORYLATES | 8 | 1.8 | 122 | 3259
|
| 28 | REGULATION | 19 | 4.3 | 66 | 2809
|
| 29 | EPIDERMAL | 14 | 3.2 | 100 | 2706
|
| 30 | CELLS | 30 | 6.8 | 135 | 2698
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 31 | ACTIVATION | 25 | 5.7 | 42 | 2691
|
| 32 | CDK | 11 | 2.5 | 42 | 2686
|
| 33 | C-JUN | 7 | 1.6 | 12 | 2635
|
| 34 | SITES | 14 | 3.2 | 42 | 2555
|
| 35 | PROTEIN-PHOSPHORYLATION | 7 | 1.6 | 63 | 2436
|
| 36 | INVITRO | 20 | 4.6 | 169 | 2419
|
| 37 | EVIDENCE | 10 | 2.3 | 105 | 2418
|
| 38 | GENE-PRODUCT | 3 | 0.7 | 76 | 2314
|
| 39 | NOVEL | 13 | 3.0 | 37 | 2251
|
| 40 | PHOSPHATASES | 9 | 2.1 | 17 | 2235
|
| 41 | ADHESION | 14 | 3.2 | 47 | 2217
|
| 42 | FOCAL | 13 | 3.0 | 47 | 2211
|
| 43 | GENE | 17 | 3.9 | 129 | 2167
|
| 44 | CELL-CYCLE | 14 | 3.2 | 53 | 2148
|
| 45 | CANCER | 3 | 0.7 | 12 | 2139
|
| 46 | CYCLINS | 3 | 0.7 | 12 | 2136
|
| 47 | SIGNAL-TRANSDUCTION | 5 | 1.1 | 32 | 2079
|
| 48 | C-FOS | 2 | 0.5 | 9 | 2071
|
| 49 | INDUCES | 6 | 1.4 | 50 | 2038
|
| 50 | INHIBITOR | 7 | 1.6 | 26 | 2035
|
| 51 | ANALYSIS | 11 | 2.5 | 73 | 1984
|
| 52 | FACTOR | 12 | 2.7 | 24 | 1928
|
| 53 | PROTEIN-KINASE-C | 9 | 2.1 | 30 | 1884
|
| 54 | EXPRESSION | 20 | 4.6 | 78 | 1862
|
| 55 | INVIVO | 9 | 2.1 | 105 | 1832
|
| 56 | CYCLIN-A | 7 | 1.6 | 41 | 1811
|
| 57 | INHIBITORS | 4 | 0.9 | 12 | 1808
|
| 58 | CELL | 24 | 5.5 | 35 | 1800
|
| 59 | PLATELET-DERIVED | 6 | 1.4 | 44 | 1782
|
| 60 | DNA-BINDING | 6 | 1.4 | 14 | 1717
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 61 | AGE | 1 | 0.2 | 10 | 1697
|
| 62 | CYCLIN-D | 1 | 0.2 | 10 | 1697
|
| 63 | CYCLIN-B | 6 | 1.4 | 35 | 1680
|
| 64 | ACID | 3 | 0.7 | 38 | 1662
|
| 65 | GRB | 6 | 1.4 | 46 | 1658
|
| 66 | CHARACTERIZATION | 19 | 4.3 | 107 | 1560
|
| 67 | CYCLIN | 9 | 2.1 | 36 | 1546
|
| 68 | GROWTH | 16 | 3.6 | 41 | 1546
|
| 69 | RAPID | 2 | 0.5 | 35 | 1525
|
| 70 | YANG | 1 | 0.2 | 11 | 1505
|
| 71 | YIN | 1 | 0.2 | 11 | 1505
|
| 72 | RELATED | 5 | 1.1 | 25 | 1503
|
| 73 | BINDING | 7 | 1.6 | 32 | 1494
|
| 74 | CDNA | 7 | 1.6 | 33 | 1483
|
| 75 | DETECTION | 4 | 0.9 | 34 | 1477
|
| 76 | TRKB | 5 | 1.1 | 13 | 1467
|
| 77 | SIMILAR | 3 | 0.7 | 56 | 1436
|
| 78 | PHOSPHOTYROSINE | 5 | 1.1 | 49 | 1422
|
| 79 | EGF | 3 | 0.7 | 27 | 1421
|
| 80 | CELLULOSE | 2 | 0.5 | 36 | 1402
|
| 81 | MAPPING | 2 | 0.5 | 36 | 1402
|
| 82 | PHOSPHOAMINO | 2 | 0.5 | 36 | 1402
|
| 83 | PHOSPHOPEPTIDE | 2 | 0.5 | 36 | 1402
|
| 84 | PLATES | 2 | 0.5 | 36 | 1402
|
| 85 | THIN-LAYER | 2 | 0.5 | 36 | 1402
|
| 86 | CYCLIN-CDK | 2 | 0.5 | 10 | 1337
|
| 87 | DIMENSIONAL | 1 | 0.2 | 36 | 1315
|
| 88 | SEPARATION | 1 | 0.2 | 36 | 1315
|
| 89 | SEQUENCE-SPECIFIC | 2 | 0.5 | 8 | 1292
|
| 90 | QUANTIFICATION | 1 | 0.2 | 28 | 1277
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 91 | PATHWAYS | 5 | 1.1 | 15 | 1256
|
| 92 | INTERACTION | 6 | 1.4 | 26 | 1242
|
| 93 | INTERACTS | 3 | 0.7 | 10 | 1204
|
| 94 | CYTOPLASMIC | 8 | 1.8 | 37 | 1175
|
| 95 | GENES | 3 | 0.7 | 5 | 1173
|
| 96 | RESPONSIVE | 1 | 0.2 | 5 | 1145
|
| 97 | STIMULATE | 1 | 0.2 | 5 | 1145
|
| 98 | PATHWAY | 3 | 0.7 | 20 | 1125
|
| 99 | RAS | 3 | 0.7 | 17 | 1117
|
| 100 | NUCLEAR | 9 | 2.1 | 16 | 1108
|
| 101 | CLASSIFICATION | 2 | 0.5 | 10 | 1099
|
| 102 | PP60C-SRC | 8 | 1.8 | 41 | 1076
|
| 103 | EUKARYOTIC | 4 | 0.9 | 10 | 1074
|
| 104 | THREONINE | 7 | 1.6 | 33 | 1061
|
| 105 | KINASE-C | 4 | 0.9 | 33 | 1039
|
| 106 | COOPERATION | 3 | 0.7 | 2 | 1031
|
| 107 | CELLULAR | 10 | 2.3 | 96 | 1027
|
| 108 | ESSENTIAL | 6 | 1.4 | 55 | 1022
|
| 109 | MESSENGER-RNA | 6 | 1.4 | 23 | 1012
|
| 110 | DOMAIN | 17 | 3.9 | 27 | 1005
|
| 111 | INTEGRIN-MEDIATED | 2 | 0.5 | 16 | 999
|
| 112 | LINKED | 1 | 0.2 | 16 | 999
|
| 113 | ONCOGENE | 2 | 0.5 | 5 | 990
|
| 114 | LIGASE | 9 | 2.1 | 16 | 981
|
| 115 | ISOLATION | 4 | 0.9 | 21 | 978
|
| 116 | TYR | 6 | 1.4 | 41 | 972
|
| 117 | ONCOGENES | 4 | 0.9 | 1 | 970
|
| 118 | SIGNALLING | 4 | 0.9 | 3 | 963
|
| 119 | RECOGNITION | 6 | 1.4 | 16 | 960
|
| 120 | JUN | 2 | 0.5 | 4 | 956
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 121 | RECEPTORS | 6 | 1.4 | 8 | 955
|
| 122 | ENCODES | 1 | 0.2 | 4 | 944
|
| 123 | TRANS-ACTIVATOR | 1 | 0.2 | 4 | 944
|
| 124 | TRANSCRIPTIONAL | 8 | 1.8 | 11 | 943
|
| 125 | TRANSIENT | 1 | 0.2 | 4 | 926
|
| 126 | CDC | 10 | 2.3 | 21 | 917
|
| 127 | SIGNAL | 6 | 1.4 | 15 | 916
|
| 128 | SEQUENCE | 6 | 1.4 | 27 | 909
|
| 129 | PDGF | 2 | 0.5 | 11 | 902
|
| 130 | NEGATIVELY | 3 | 0.7 | 5 | 891
|
| 131 | MURINE | 23 | 5.2 | 76 | 888
|
| 132 | DOMAIN-STRUCTURE | 1 | 0.2 | 9 | 877
|
| 133 | SUPERFAMILY | 1 | 0.2 | 9 | 877
|
| 134 | DECREASES | 1 | 0.2 | 5 | 876
|
| 135 | REGULATE | 1 | 0.2 | 5 | 876
|
| 136 | PHOSPHOLIPASE-C-GAMMA | 1 | 0.2 | 10 | 873
|
| 137 | PHOSPHORYLATED | 10 | 2.3 | 44 | 865
|
| 138 | COMPLEX | 5 | 1.1 | 15 | 863
|
| 139 | STRUCTURAL | 8 | 1.8 | 25 | 856
|
| 140 | NEGATIVE | 3 | 0.7 | 10 | 849
|
| 141 | REGULATOR | 2 | 0.5 | 10 | 815
|
| 142 | SRC | 7 | 1.6 | 124 | 813
|
| 143 | CONTROL | 7 | 1.6 | 10 | 809
|
| 144 | SITE | 11 | 2.5 | 56 | 791
|
| 145 | DIFFERENTLY | 2 | 0.5 | 20 | 781
|
| 146 | SYNTHETIC | 4 | 0.9 | 15 | 759
|
| 147 | DEPENDENT | 4 | 0.9 | 16 | 753
|
| 148 | TARGET | 3 | 0.7 | 31 | 746
|
| 149 | ADENOVIRUS | 5 | 1.1 | 28 | 741
|
| 150 | P34-CDC | 1 | 0.2 | 17 | 735
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 151 | PROTEIN-REGULATION | 1 | 0.2 | 17 | 735
|
| 152 | MITOGEN-ACTIVATED | 5 | 1.1 | 12 | 733
|
| 153 | ERK | 5 | 1.1 | 13 | 719
|
| 154 | LIGANDS | 3 | 0.7 | 4 | 714
|
| 155 | C-KINASE | 2 | 0.5 | 15 | 700
|
| 156 | FACTOR-STIMULATED | 1 | 0.2 | 15 | 700
|
| 157 | REDUCES | 2 | 0.5 | 15 | 700
|
| 158 | INTEGRIN | 4 | 0.9 | 8 | 694
|
| 159 | IDENTIFICATION | 16 | 3.6 | 49 | 681
|
| 160 | CASEIN | 5 | 1.1 | 4 | 680
|
| 161 | ONCOGENIC | 2 | 0.5 | 1 | 675
|
| 162 | GENOME | 8 | 1.8 | 11 | 674
|
| 163 | DNA | 11 | 2.5 | 12 | 670
|
| 164 | PLASMA-MEMBRANE | 5 | 1.1 | 36 | 670
|
| 165 | BEHAVES | 1 | 0.2 | 19 | 658
|
| 166 | E1A-ASSOCIATED | 1 | 0.2 | 19 | 658
|
| 167 | POLYOMA | 12 | 2.7 | 46 | 658
|
| 168 | PROTEIN-P | 1 | 0.2 | 19 | 658
|
| 169 | UBIQUITIN-PROTEIN | 3 | 0.7 | 12 | 653
|
| 170 | DIFFERENTIALLY | 2 | 0.5 | 11 | 623
|
| 171 | FUNCTION | 13 | 3.0 | 16 | 608
|
| 172 | ONCOPROTEIN | 2 | 0.5 | 3 | 606
|
| 173 | HUMAN-TUMOR | 1 | 0.2 | 31 | 599
|
| 174 | RAT | 10 | 2.3 | 13 | 598
|
| 175 | PROMOTES | 3 | 0.7 | 7 | 593
|
| 176 | CLOSE | 3 | 0.7 | 25 | 588
|
| 177 | FACE | 3 | 0.7 | 25 | 588
|
| 178 | CYTOSKELETAL | 3 | 0.7 | 31 | 587
|
| 179 | E2-DEPENDENT | 2 | 0.5 | 15 | 586
|
| 180 | CALPACTIN-I | 6 | 1.4 | 10 | 580
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 181 | REVEALS | 4 | 0.9 | 6 | 577
|
| 182 | FACTORS | 2 | 0.5 | 5 | 575
|
| 183 | RESIDUE | 3 | 0.7 | 18 | 571
|
| 184 | LOCATED | 2 | 0.5 | 9 | 564
|
| 185 | TRANSPORT | 1 | 0.2 | 9 | 564
|
| 186 | UNDERGO | 1 | 0.2 | 9 | 564
|
| 187 | FULL-LENGTH | 1 | 0.2 | 7 | 559
|
| 188 | NEURAL | 1 | 0.2 | 7 | 559
|
| 189 | TRUNCATED | 1 | 0.2 | 7 | 559
|
| 190 | PHYSIOLOGICAL | 2 | 0.5 | 4 | 553
|
| 191 | MOUSE | 7 | 1.6 | 13 | 544
|
| 192 | VINCULIN | 1 | 0.2 | 26 | 540
|
| 193 | BRAIN-DERIVED | 1 | 0.2 | 4 | 538
|
| 194 | NEUROTROPHIC | 1 | 0.2 | 4 | 538
|
| 195 | NEUROTROPHIN | 1 | 0.2 | 4 | 538
|
| 196 | PEPTIDE | 12 | 2.7 | 24 | 530
|
| 197 | BASIS | 3 | 0.7 | 14 | 525
|
| 198 | COMPLEMENT | 1 | 0.2 | 4 | 519
|
| 199 | HEAVY-CHAIN | 4 | 0.9 | 7 | 512
|
| 200 | MAP | 3 | 0.7 | 8 | 504
|
Page 1 of 7: [ 1 2 3 4 5 6 7 ]